Rare diseases
Showing of 15 results
Oxford-Harrington Rare Disease Centre Announces David Cameron, Chair of its Advisory Council, as a Guest Speaker at Morgan Stanley Exchange 2025
In ‘A Conversation on Courage,’ Lord Cameron and Morgan Stanley’s Andy Saperstein discussed philanthropy as a catalyst for rare disease innovation.
Harrington Discovery Institute Announces 2025 Scholar-Innovator Award Recipients
Drug development grant will advance 10 physician-scientists’ discoveries toward the clinic.
Oxford-Harrington Rare Disease Centre Appoints Majid Jafar to its Advisory Council
Mr. Jafar is a distinguished international business leader and co-founder of the Loulou Foundation.
Top Neuroscientist Matthew Anderson Appointed Co-Director of the Oxford-Harrington Rare Disease Centre
Renowned US Neuroscientist and Harvard Professor brings extensive expertise in academia and industry to advance rare disease research.
Synergy for Change Award to Morgan Stanley GIFT and Harrington Discovery Institute
Award highlights collaboration between for profit and non-profit achieving great impact.
Oxford-Harrington Rare Disease Centre Opens 2025 Call for Proposals
Scholar Award Accelerates Novel Therapies for Rare Diseases.
The Oxford-Harrington Rare Disease Centre (OHC) Announces Inaugural 2024 Rare Disease Scholar Award Recipients
10 scientists have been selected for OHC’s first annual award to advance academic discoveries into clinical practice for rare diseases.
Former UK Prime Minister David Cameron Joins Oxford-Harrington Rare Disease Centre (OHC) as Chair of its Advisory Council
Lord Cameron will lead international efforts to drive the OHC’s mission of delivering 40 new therapies for rare diseases into clinical trials over the next ten years.